Comparison of doxorubicin–cyclophosphamide with doxorubicin–dacarbazine for the adjuvant treatment of canine hemangiosarcoma
Sign Up to like & getrecommendations! Published in 2017 at "Veterinary and Comparative Oncology"
DOI: 10.1111/vco.12139
Abstract: Canine hemangiosarcoma (HSA) is a neoplasm of vascular endothelial origin that has an aggressive biological behaviour, with less than 10% of dogs alive at 12-months postdiagnosis. Treatment of choice consists of surgery followed by adjuvant… read more here.
Keywords: doxorubicin cyclophosphamide; treatment; doxorubicin dacarbazine; doxorubicin ... See more keywords
Abstract A005: Canine hemangiosarcoma as a model for RAS-mutated human cancers: Preliminary data
Sign Up to like & getrecommendations! Published in 2023 at "Molecular Cancer Research"
DOI: 10.1158/1557-3125.ras23-a005
Abstract: Canine cancer patients represent an important translational model for human cancer research with their spontaneous tumor pathogenesis and the many histological, genetic, molecular and clinical similarities between canine and human tumors. Canine tumors provide an… read more here.
Keywords: canine hemangiosarcoma; canine; missense mutations; human cancers ... See more keywords